Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03962504 · ClinicalTrials.gov registry record · NA
Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT03962504: Completed NA study, sponsored by VA Office of Research and Development.
NCT03962504 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03962504, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
The goal of this study is to examine whether a brief, exposure-based treatment (Written Exposure Therapy) approach is just as effective in the treatment of posttraumatic stress disorder (PTSD) compared with a more commonly used time-intensive approach called Prolonged Exposure. One hundred and fifty Veterans diagnosed with PTSD will be randomly assigned to either Written Exposure therapy or Prolonged Exposure. Veteran participants will be assessed at pre-treatment, and 10-, 20-, and 30- weeks post first treatment session. Primary outcome measure will be PTSD symptom severity. The secondary outcome measure will be quality of life. In addition, treatment dropout during the first five sessions will be examined. WET is expected to have a lower treatment dropout rate relative to PE.
Interventions
- BEHAVIORAL trauma-focused treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03962504
The ClinicalTrials.gov registry entry for NCT03962504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which trauma-focused treatment is the first listed.
NCT03962504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03962504 about?
NCT03962504 is a clinical study titled "Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial". The goal of this study is to examine whether a brief, exposure-based treatment (Written Exposure Therapy) approach is just as effective in the treatment of posttraumatic stress disorder (PTSD) compared with a more commonly used time-intensive approach called Prolonged Exposure. One hundred and fifty...
What is the current status of trial NCT03962504?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2019-09-09. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT03962504?
The interventions under investigation include: trauma-focused treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03962504?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.